USD 4.88
| ticker | 1 day return % | 1 week return % | 1 month return % | 3 months return % | 6 months return % | 1 year return % | 3 years return % | 5 years return % | 10 years return % | maximum return % |
|---|---|---|---|---|---|---|---|---|---|---|
| IDBA | 0 | 9.7 | 1.7 | -3.4 | -38.3 | -24.8 | -82.7 | -82.7 | -82.7 | -82.7 |
| S&P 500 | 1.0 | 3.7 | 2.1 | 2.3 | 8.2 | 25.4 | 31.0 | 80.6 | 196.5 | 33856.2 |
Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline
Feel free to experiment with these tools to enhance your technical analysis. Remember, any drawings you make are temporary and will be lost upon refreshing the page unless saved as an image using the 'Camera' icon.
Get instant AI-powered professional insights on prices:
💡Generate AI Technical Analysis ReportA Multi-Interval Candlestick Chart displays the price movements of an asset over different time intervals. Each candlestick represents the open, high, low, and close prices for a specific interval. The chart can be used to identify trends and patterns in price movements.
| Attribute | Value |
|---|---|
| symbol | IDBA |
| name | IDEX Biometrics ASA |
| price | 4.88 |
| changes percentage | 1.6667 |
| change | 0.08 |
| day low | 4.334 |
| day high | 4.88 |
| year high | 11.15 |
| year low | 4.33 |
| market cap | 90786544 |
| price avg 50 | 5.19752 |
| price avg 200 | 6.647155 |
| exchange | NASDAQ |
| volume | 4535 |
| avg volume | 1419 |
| open | 4.67 |
| previous close | 4.8 |
| eps | -2.43 |
| pe | -2.00823 |
| earnings announcement | 2023-11-09T05:00:00.000+0000 |
| shares outstanding | 18603800 |
| timestamp | 2023-08-09 13:56:14 |
We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0000000000 | |||
| revenue | 4152076 | 4092000 | 1.47 |
| gross profit | 231730 | 848000 | -72.67 |
| gross profit ratio | 0.06 | 0.21 | -73.07 |
| research and development expenses | 3647853 | 3250000 | 12.24 |
| operating expenses | 27163546 | 32217000 | -15.69 |
| interest income | 878824 | 97000 | 806.00 |
| interest expense | 666946 | 33000 | 1921.05 |
| ebitda | -25901571 | -29921000 | 13.43 |
| ebitdaratio | -6.24 | -7.31 | 14.69 |
| operating income | -26931816 | -31369000 | 14.15 |
| operating income ratio | -6.49 | -7.67 | 15.39 |
| net income | -26713127 | -32660000.0 | 18.21 |
| net income ratio | -6.43 | -7.98 | 19.40 |
| eps | -1.07 | -0.15 | -613.33 |
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0000000000 | |||
| revenue | 61260 | 386288.79 | -84.14 |
| gross profit | -1484535 | 152508.8 | -1073.41 |
| gross profit ratio | -24.23 | 0.39 | -6238.05 |
| research and development expenses | 1422254 | 635119.09 | 123.94 |
| operating expenses | 2650519 | 6146508.15 | -56.88 |
| interest income | 5104.92 | 13142.3 | -61.16 |
| interest expense | 605453 | 551977.01 | 9.69 |
| ebitda | 1616244 | -4891320.18 | 133.04 |
| ebitdaratio | 26.38 | -12.66 | 308.36 |
| operating income | -4135055.38 | -5993999.35 | 31.01 |
| operating income ratio | -67.5 | -15.52 | -335.01 |
| net income | 1388561 | -6691325.96 | 120.75 |
| net income ratio | 22.67 | -17.32 | 230.85 |
| eps | 0.05 | -0.02 | 306.16 |
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0000000000 | |||
| total assets | 25040861 | 29016000 | -13.70 |
| total liabilities | 13671054 | 6175000 | 121.39 |
| total equity | 11369806 | 22841000 | -50.22 |
| cash and cash equivalents | 11387863 | 16124000 | -29.37 |
| short term investments | 0 | 0 | NaN |
| long term investments | 81225 | 719123 | -88.70 |
| total current assets | 20376170 | 23835000 | -14.51 |
| total non current assets | 4664690 | 5181000 | -9.97 |
| total current liabilities | 12429143 | 5033000 | 146.95 |
| total non current liabilities | 1241911 | 1142000 | 8.75 |
| common stock | 26036998 | 22762000 | 14.39 |
| retained earnings | -331072646 | -303401000 | -9.12 |
| total debt | 6959918 | 1544000 | 350.77 |
Total Assets: Total Assets decreased to 25 million in 2023 from 29 million in 2022 representing a change of -13.7%. Suggesting a decrease in asset holdings.
Total Liabilities: Total Liabilities increased to 14 million in 2023 from 6 million in 2022 representing a change of 121.39%. This indicates an increase in overall liabilities.
Total Equity: Total Equity decreased to 11 million in 2023 from 23 million in 2022 representing a change of -50.22%. This indicates a decrease in shareholders' equity.
Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 11 million in 2023 from 16 million in 2022 representing a change of -29.37%. This indicates a decrease in available liquid assets.
Total Current Assets: Total Current Assets decreased to 20 million in 2023 from 24 million in 2022 representing a change of -14.51%. This indicates a worsen liquidity position.
Total Current Liabilities: Total Current Liabilities increased to 12 million in 2023 from 5 million in 2022 representing a change of 146.95%. This indicates a higher short-term debt burden.
Retained Earnings: Retained Earnings decreased to -331 million in 2023 from -303 million in 2022 representing a change of -9.12%. This indicates an accumulated losses.
Total Debt: Total Debt increased to 7 million in 2023 from 2 million in 2022 representing a change of 350.77%. This indicates an increase in overall debt burden.
Common Stock: Common Stock increased to 26 in 2023 from 23 in 2022 representing a change of 14.39%. This indicates an increase in ownership interest.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0000000000 | |||
| total assets | 13051540 | 14646870 | -10.89 |
| total liabilities | 7292267 | 12143517 | -39.95 |
| total equity | 5760278 | 2503352.54 | 130.10 |
| cash and cash equivalents | 1085954 | 2063886.2 | -47.38 |
| short term investments | 0 | 0 | NaN |
| long term investments | 85389 | 81053.63 | 5.35 |
| total current assets | 10611408 | 11696024 | -9.27 |
| total non current assets | 2440131 | 2950845.7 | -17.31 |
| total current liabilities | 4905378 | 11172276 | -56.09 |
| total non current liabilities | 2386888 | 971240.63 | 145.76 |
| common stock | 12466873 | 10626455 | 17.32 |
| retained earnings | -342319653 | -343264323 | 0.28 |
| total debt | 2776667 | 4182956.63 | -33.62 |
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0000000000 | |||
| net change in cash | -4208826.9 | -17635000 | 76.13 |
| operating cash flow | -27090315 | -31897000 | 15.07 |
| free cash flow | -27334083 | -32164000 | 15.02 |
| capital expenditure | -243767.62 | -267000 | 8.70 |
| depreciation and amortization | 1706506 | 1352000 | 26.22 |
| deferred income tax | 0 | 0 | NaN |
| stock based compensation | 1287053 | 2721000 | -52.70 |
| accounts payables | -889262.13 | 858000 | -203.64 |
| inventory | -1943119.41 | -3215000 | 39.56 |
| acquisitions net | 0 | 0 | NaN |
| investments in property plant and equipment | -243767.62 | -267000 | 8.70 |
| net cash used for investing activites | 4012.63 | -160000 | 102.51 |
| debt repayment | 80768264 | -400000 | 20292.07 |
| common stock issued | 14899316 | 14376000 | 3.64 |
| common stock repurchased | 0 | 0 | NaN |
| dividends paid | 0 | 0 | NaN |
| net cash used provided by financing activities | 23197010 | 14503000 | 59.95 |
| cash at end of period | 11387863 | 16124000 | -29.37 |
| accounts receivables | 371168 | -548000 | 167.73 |
| cash at beginning of period | 15596690 | 33759000 | -53.80 |
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0000000000 | |||
| operating cash flow | -2323205.2 | -5056872.51 | 54.06 |
| free cash flow | -0.2 | -5042040.61 | 100.00 |
| capital expenditure | 2323205 | 14831.89 | 15563.58 |
| depreciation and amortization | -379812.48 | 1103682.51 | -134.41 |
| deferred income tax | 0 | 0 | NaN |
| stock based compensation | 0 | -95317.97 | 100.00 |
| accounts receivables | 170610 | 234783.33 | -27.33 |
| accounts payables | 1408409 | 171581.39 | 720.84 |
| inventory | -98469.08 | 119398.35 | -182.47 |
| acquisitions net | -30239.11 | 222010 | -113.62 |
| investments in property plant and equipment | 2323205 | 14831.89 | 15563.58 |
| net cash used for investing activites | -31255.08 | 249833.55 | -112.51 |
| debt repayment | -4722855 | -1846960 | -155.71 |
| common stock issued | 1937720 | 4882277.99 | -60.31 |
| common stock repurchased | 0 | 0 | NaN |
| dividends paid | 0 | 0 | NaN |
| net cash used provided by financing activities | 1340583 | 3817738.1 | -64.89 |
| net change in cash | -1003005.62 | -1034594.54 | 3.05 |
| cash at end of period | 1085954 | 2063886.2 | -47.38 |
| cash at beginning of period | 2088959 | 3098480.73 | -32.58 |
EPS represents the portion of a company's profit allocated to each outstanding share of common stock. A higher EPS is generally favorable, indicating stronger profitability on a per-share basis.
Positive EPS: A positive EPS signifies that a company is profitable, it is generally viewed positively, supporting stock value and investor confidence.
Negative EPS: Indicates that a company is operating at a loss, which could lead to negative sentiment, potential stock depreciation, and concerns about the company's financial health.
The Next Earning Date represents when the company plans to release its next set of financial results.
An upward trend in EPS suggests consistent growth in earnings, often leading to increased investor confidence. A downward trend may indicate a decline in earnings, potentially decreasing investor confidence and stock value. Fluctuating EPS suggests unpredictable financial performance, warranting cautious investor analysis.
Earnings surprise occurs when a company's actual earnings differ from analysts' expectations. A positive earnings surprise typically reflects better-than-expected performance, potentially leading to stock appreciation. Conversely, a negative earnings surprise can result in stock depreciation. An earnings surprise of zero means the earnings met expectations, which typically has a neutral impact on stock price.
Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.
| 2023-12-31 | 2022-12-31 | Y/Y change % | |
|---|---|---|---|
| FY | |||
| calendar year | 2023 | 2022 | NaN |
| revenue per share | 0.02 | 0.02 | -17.64 |
| net income per share | -0.11 | -0.16 | 33.61 |
| operating cash flow per share | -0.11 | -0.16 | 31.06 |
| free cash flow per share | -0.11 | -0.16 | 31.02 |
| cash per share | 0.05 | 0.08 | -42.67 |
| book value per share | 0.04 | 0.11 | -59.60 |
| tangible book value per share | 0.04 | 0.1 | -62.63 |
| shareholders equity per share | 0.04 | 0.11 | -59.60 |
| interest debt per share | 0.03 | 0.01 | 292.55 |
| market cap | 68624705.28 | 104697552.5 | -34.45 |
| enterprise value | 64196760.28 | 90117552.5 | -28.76 |
| pe ratio | -2.57 | -3.21 | 19.86 |
| price to sales ratio | 16.53 | 25.59 | -35.40 |
| pocfratio | -2.53 | -3.28 | 22.82 |
| pfcf ratio | -2.51 | -3.26 | 22.87 |
| pb ratio | 6.04 | 4.58 | 31.68 |
| ptb ratio | 6.04 | 4.58 | 31.68 |
| ev to sales | 15.46 | 22.02 | -29.79 |
| enterprise value over ebitda | -2.48 | -3.01 | 17.71 |
| ev to operating cash flow | -2.37 | -2.83 | 16.12 |
| ev to free cash flow | -2.35 | -2.8 | 16.18 |
| earnings yield | -0.39 | -0.31 | -24.79 |
| free cash flow yield | -0.4 | -0.31 | -29.66 |
| debt to equity | 0.61 | 0.07 | 805.56 |
| debt to assets | 0.28 | 0.05 | 422.33 |
| net debt to ebitda | 0.17 | 0.49 | -64.92 |
| current ratio | 1.64 | 4.74 | -65.38 |
| interest coverage | -40.38 | -950.58 | 95.75 |
| income quality | 1.01 | 0.98 | 3.96 |
| dividend yield | 0 | 0 | NaN |
| payout ratio | 0 | 0 | NaN |
| sales general and administrative to revenue | 0 | 4.7 | -100.00 |
| research and ddevelopement to revenue | 0.88 | 0.79 | 10.62 |
| intangibles to total assets | 0.08 | 0.08 | -6.34 |
| capex to operating cash flow | -0.01 | -0.01 | -7.50 |
| capex to revenue | 0.06 | 0.07 | -10.02 |
| capex to depreciation | 0.14 | 0.2 | -27.67 |
| stock based compensation to revenue | 0.31 | 0.66 | -53.38 |
| graham number | 0.33 | 0.63 | -48.21 |
| roic | -1.12 | -1.28 | 12.88 |
| return on tangible assets | -1.16 | -1.23 | 5.78 |
| graham net net | 0.01 | 0.07 | -90.33 |
| working capital | 7947027 | 18802000 | -57.73 |
| tangible asset value | 9384555 | 20385000 | -53.96 |
| net current asset value | 6705116 | 17660000 | -62.03 |
| invested capital | 12530484 | 23910000 | -47.59 |
| average receivables | 1630046 | 1909500 | -14.63 |
| average payables | 1115086.5 | 1112500 | 0.23 |
| average inventory | 5424377 | 2840500 | 90.97 |
| days sales outstanding | 86.33 | 203.19 | -57.51 |
| days payables outstanding | 64.26 | 173.27 | -62.92 |
| days of inventory on hand | 596.03 | 500.36 | 19.12 |
| receivables turnover | 4.23 | 1.8 | 135.36 |
| payables turnover | 5.68 | 2.11 | 169.65 |
| inventory turnover | 0.61 | 0.73 | -16.05 |
| roe | -2.35 | -1.43 | -64.31 |
| capex per share | 0.0 | 0.0 | -25.89 |
ROE: Return on Equity (ROE) decreased to -2.35 on 2023-12-31 from -1.43 on 2022-12-31, representing a change of -64.31%. Suggesting that the company has not been generating high returns for its shareholders.
PE Ratio: Price-to-Earnings (P/E) Ratio increased to -2.57 on 2023-12-31 from -3.21 on 2022-12-31, representing a change of 19.86%. Indicating an increase in the relative valuation of the company's stock.
Current Ratio: Current Ratio decreased to 1.64 on 2023-12-31 from 4.74 on 2022-12-31, representing a change of -65.38%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.
Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.61 on 2023-12-31 from 0.07 on 2022-12-31, representing a change of 805.56%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
| 2024-09-30 Q3 | 2024-06-30 Q2 | Q/Q change % | |
|---|---|---|---|
| IDBA | |||
| calendar year | 2024 | 2024 | NaN |
| revenue per share | 0.0 | 0.0 | -8.524000e+01 |
| net income per share | 0.0 | -0.02 | 1.193200e+02 |
| operating cash flow per share | -0.01 | -0.02 | 5.723000e+01 |
| free cash flow per share | -0.0 | -0.02 | 1.000000e+02 |
| cash per share | 0.0 | 0.01 | -5.102000e+01 |
| book value per share | 0.02 | 0.01 | 1.141800e+02 |
| tangible book value per share | 0.01 | 0.0 | 4.076500e+02 |
| shareholders equity per share | 0.02 | 0.01 | 1.142100e+02 |
| interest debt per share | 0.01 | 0.02 | -3.350000e+01 |
| market cap | 6098782.12 | 39734214.68 | -8.465000e+01 |
| enterprise value | 7789495.12 | 41853285.11 | -8.139000e+01 |
| pe ratio | 1.1 | -1.48 | 1.739600e+02 |
| price to sales ratio | 99.56 | 102.86 | -3.210000e+00 |
| pocfratio | -2.63 | -7.86 | 6.659000e+01 |
| pfcf ratio | -30493910.58 | -7.88 | -3.869499e+08 |
| pb ratio | 1.06 | 15.87 | -9.333000e+01 |
| ptb ratio | 1.06 | 15.87 | -9.333000e+01 |
| ev to sales | 127.15 | 108.35 | 1.736000e+01 |
| enterprise value over ebitda | 4.82 | -8.56 | 1.563200e+02 |
| ev to operating cash flow | -3.35 | -8.28 | 5.949000e+01 |
| ev to free cash flow | -38947475.57 | -8.3 | -4.691978e+08 |
| earnings yield | 0.23 | -0.17 | 2.352000e+02 |
| free cash flow yield | -0.0 | -0.13 | 1.000000e+02 |
| debt to equity | 0.48 | 1.67 | -7.115000e+01 |
| debt to assets | 0.21 | 0.29 | -2.551000e+01 |
| net debt to ebitda | 1.05 | -0.43 | 3.414600e+02 |
| current ratio | 2.16 | 1.05 | 1.066400e+02 |
| interest coverage | -6.83 | -10.86 | 3.711000e+01 |
| income quality | -1.67 | 0.76 | -3.213900e+02 |
| dividend yield | 0 | 0 | NaN |
| payout ratio | 0 | 0 | NaN |
| sales general and administrative to revenue | 0 | 0 | NaN |
| research and ddevelopement to revenue | 23.22 | 1.64 | 1.312070e+03 |
| intangibles to total assets | 0.12 | 0.12 | 4.680000e+00 |
| capex to operating cash flow | -1.0 | -0.0 | -3.399459e+04 |
| capex to revenue | 37.92 | 0.04 | 9.867025e+04 |
| capex to depreciation | -6.12 | 0.01 | -4.561620e+04 |
| stock based compensation to revenue | 0 | -0.25 | 1.000000e+02 |
| graham number | 0.04 | 0.07 | -3.567000e+01 |
| roic | 1.64 | -0.43 | 4.837800e+02 |
| return on tangible assets | 0.12 | -0.52 | 1.234400e+02 |
| graham net net | -0.0 | -0.02 | 7.608000e+01 |
| working capital | 5706030 | 523748 | 9.894600e+02 |
| tangible asset value | 4130845 | 757528.02 | 4.453100e+02 |
| net current asset value | 3319141 | -447493 | 8.417200e+02 |
| invested capital | 8061775 | 3393322.41 | 1.375800e+02 |
| average receivables | 1526262 | 1249687.77 | 2.213000e+01 |
| average payables | 1611793.19 | 821827.49 | 9.612000e+01 |
| average inventory | 6381735.23 | 6338782.22 | 6.800000e-01 |
| days sales outstanding | 2805.65 | 266.26 | 9.537300e+02 |
| days payables outstanding | 134.53 | 351.5 | -6.173000e+01 |
| days of inventory on hand | 374.62 | 2436.57 | -8.462000e+01 |
| receivables turnover | 0.03 | 0.34 | -9.051000e+01 |
| payables turnover | 0.67 | 0.26 | 1.612900e+02 |
| inventory turnover | 0.24 | 0.04 | 5.504000e+02 |
| roe | 0.24 | -2.67 | 1.090200e+02 |
| capex per share | 0.01 | 0.0 | 1.448204e+04 |
ROE: Return on Equity (ROE) increased to 0.24 on 2024-09-30 Q3 from -2.67 on 2024-06-30 Q2, representing a change of 109.02%. Suggesting the company has been generating high returns for its shareholders.
PE Ratio: Price-to-Earnings (P/E) Ratio increased to 1.10 on 2024-09-30 Q3 from -1.48 on 2024-06-30 Q2, representing a change of 173.96%. Indicating an increase in the relative valuation of the company's stock.
Current Ratio: Current Ratio increased to 2.16 on 2024-09-30 Q3 from 1.05 on 2024-06-30 Q2, representing a change of 106.64%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.
Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.48 on 2024-09-30 Q3 from 1.67 on 2024-06-30 Q2, representing a change of -71.15%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
None
| Market Capitalization | Enterprise Value | |
|---|---|---|
| Definition | The total market value of a company's outstanding shares | The total market value of a company, including its debt and other liabilities |
| Calculation | Current share price * Total number of outstanding shares | Market capitalization + Total debt - Cash and cash equivalents |
| Focus | Equity component of a company's value | Total economic value of a company |
| Usefulness | Assesses a company's size and growth potential based on investor sentiment | Provides a more comprehensive valuation that considers both equity and debt |
Analyzing dividends is a crucial aspect of investment evaluation, offering valuable insights into a company's financial health and its commitment to shareholder returns. Dividends represent a portion of a company's profits distributed to its shareholders, providing a steady income stream. We help you analyze dividends based on the indicators mentioned below:
• Investors often assess the average dividend amount, observing trends over time to gauge the company's stability and growth potential. A positive trend in average dividends indicates a consistent and potentially lucrative investment. Additionally, evaluating the trend of dividend increases provides insight into the company's financial strength and management's confidence in future earnings.
• Consistency in paying dividends is a reassuring sign, reflecting a company's reliability and commitment to shareholder value. For investors, dividends not only offer income but also contribute to the overall total return on investment.
• Companies with a history of regular and increasing dividends can attract income-focused investors seeking stable returns, making dividends a critical factor in building a well-rounded investment portfolio.
Interested in the overall sentiment for a particular period? Check out our news sentiment analysis tool.
Sentiment: Positive
Publish Date: 2025-01-08 03:02:00
IDEX Biometrics has received an order for solution development and subsequent delivery of biometric sensor systems from US client DigAware, a product company of Emnovate, to target enterprises with its unique biometric physical access solutions across the United States and globally.
Sentiment: Positive
Publish Date: 2024-12-12 01:30:00
Reference is made to the private placement (the “Private Placement”) completed in IDEX Biometrics ASA (the “Company”) on 17 September 2024, and to the subsequent offering completed in the Company on 29 November 2024 (the “Subsequent Offering”). The subscribers in the Private Placement and the Subsequent Offering were allocated two warrants, Warrants A and Warrants B (collectively, the “Warrants”), respectively, issued by the Company for every two Offer Shares allocated to, and paid by, them in the Private Placement and the Subsequent Offering. As previously announced by the Company, the Company shall use reasonable efforts to seek to ensure that the Warrants are admitted to trading on Euronext Oslo Børs.
Sentiment: Positive
Publish Date: 2024-12-10 06:45:00
Reference is made to the stock exchange announcement by IDEX Biometrics ASA (the “Company”) on 2 December 2024 regarding the completion of the subsequent offering in the Company raising gross proceeds of approximately NOK 3.9 million by issuance of 26,160,420 new shares (the “Offer Shares”).
Sentiment: Positive
Publish Date: 2024-12-03 02:50:00
� Reference is made to the subsequent offering in IDEX Biometrics ASA (the “Company”) approved by the Extraordinary General Meeting on 9 October 2024, including notifications with regards to primary insiders' subscriptions on 28 November 2024 and 2 December 2024.
Sentiment: Positive
Publish Date: 2024-12-02 09:40:00
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN, HONG KONG OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.
Sentiment: Positive
Publish Date: 2024-12-02 02:55:00
Reference is made to the subsequent offering in IDEX Biometrics ASA (the “Company”) approved by the Extraordinary General Meeting on 9 October 2024.
Sentiment: Neutral
Publish Date: 2024-11-30 12:50:00
Reference is made to the stock exchange notices from IDEX Biometrics ASA on 13 November 2024 and 26 November 2024 regarding the subscription period (the “Subscription Period”), in the subsequent offering (the “Subsequent Offering”).
Sentiment: Positive
Publish Date: 2024-11-29 06:00:00
Reference is made to the stock exchange notices from IDEX Biometrics ASA on 13 November 2024 and 26 November 2024 regarding the subscription period (the “Subscription Period”), in the subsequent offering (the “Subsequent Offering”) consisting of up to 140 million new shares at a subscription price of NOK 0.15 per share.
Sentiment: Neutral
Publish Date: 2024-11-28 02:30:00
�
Sentiment: Positive
Publish Date: 2024-11-27 07:20:00
Kristian Flaten, CFO in IDEX Biometrics ASA, has today bought 1,000,000 shares in IDEX Biometrics ASA, at an average price of NOK 0.1180 per share.
Sentiment: Positive
Publish Date: 2024-11-26 03:00:00
Oslo, Norway – 26 November 2024. Following the private placement on 16. September 2024 (the “Private Placement”), IDEX Biometrics ASA (the “Company”) is conducting a subsequent offering (repair issue) of up to 140 million shares at NOK 0.15 per share. Shareholders who participate in this offering will also receive warrants to subscribe for additional shares at the same price (NOK 0.15 per share).
Sentiment: Positive
Publish Date: 2024-11-19 04:15:00
Oslo, Norway, and Seoul, South Korea 19 November 2024 – IDEX Biometrics has entered into a commercial development agreement with South Korean smart card manufacturer Cellfie Global (formerly ICK) to design, manufacture and market biometric metal and PVC cards for bank and fintech launches in USA, Europe and Asia. This gives IDEX Biometrics full coverage across all four card manufacturers in South Korea, representing a production capacity in excess of 100 million smart cards annually, and with world leading metal card manufacturing capabilities.
Sentiment: Positive
Publish Date: 2024-11-13 12:00:00
Reference is made to the stock exchange announcement issued by IDEX Biometrics ASA (the “Company”) on 17 September 2024 regarding the successful private placement of 466,666,666 new shares (“Private Placement” and the “Private Placement Shares”), and the possible subsequent offering of up to 140,000,000 new shares (“Subsequent Offering” and the “Subsequent Offering Shares”).
Sentiment: Positive
Publish Date: 2024-10-29 03:10:00
Oslo, Norway – October 29, 2024 – IDEX Biometrics has appointed Kristian Flaten as Chief Financial Officer, effective November 1, 2024.
Sentiment: Neutral
Publish Date: 2024-10-29 03:00:00
Oslo, Norway – 29 October 2024 - IDEX Biometrics ASA's interim report for the third quarter is attached to this notice (link below). The interim report is also available on the IDEX Biometrics website: www.idexbiometrics.com/investors/interim-results/
* The sentiment analysis presented is generated through an algorithm and may be subject to inaccuracies. Users are advised to corroborate key information and employ further analytical methods prior to making critical decisions.
Get instant AI-powered professional insights:
💡Generate AI Technical Analysis ReportUnderstand the chart below:
Interpret Technical Indicators
| Indicator | Bullish | Bearish |
|---|---|---|
| Price and EMA ⓘ | Price crosses above EMA | Price crosses below EMA |
| Short-Term vs Long-Term EMA ⓘ | Short EMA crosses above Long EMA | Short EMA crosses below Long EMA |
| Volume ⓘ | Increasing volume during price uptrend | Increasing volume during price downtrend |
| MACD ⓘ | MACD crosses above Signal Line | MACD crosses below Signal Line |
| RSI ⓘ | RSI is below 30 (oversold) and starts to rise above 30 | RSI is above 70 (overbought) and starts to decline below 70 |
| Candlestick Patterns ⓘ | Bullish candlestick patterns | Bearish candlestick patterns |
Copyright © 2024 Sirius Investors
All rights reserved
